Skip to main content
main-content

Spondyloarthropathies

EULAR 2019

Bimekizumab trials in spondyloarthritis

Doctor and needle
EULAR 2019

The SPIRIT-H2H trial

Head-to-head
EULAR 2019

Tildrakizumab for the treatment of PsA

Antibodies (illustration)
medwireNews top story

Biomarker panel may help differentiate PsA from osteoarthritis

Blood test tubes

A panel of four soluble biomarkers comprising markers of cartilage metabolism, metabolic syndrome, and inflammation could distinguish psoriatic arthritis from osteoarthritis, researchers report.

medwireNews top story

Certolizumab pegol shows promise for nonradiographic axSpA

Spine

The tumor necrosis factor inhibitor certolizumab pegol could be an option for patients with active nonradiographic axial spondyloarthritis and objective signs of inflammation, indicate phase III trial results.

15-06-2019 | Psoriatic arthritis | EULAR 2019 | Article

Researcher comment: The SPIRIT-H2H trial

Lead investigator Philip Mease discusses the findings from the SPIRIT-H2H trial, a phase III head-to-head trial of ixekizumab versus adalimumab in patients with psoriatic arthritis (7:15).

12-06-2019 | Psoriatic arthritis | EULAR 2019 | Article

Researcher comment: Tildrakizumab shows promise for PsA

Lead investigator Philip Mease outlines the results of a phase IIb trial supporting further development of the anti-interleukin-23p19 monoclonal antibody tildrakizumab for the treatment of psoriatic arthritis (8:45).

10-06-2019 | Psoriatic arthritis | Feature | Article

A closer look at guidelines for the management of PsA

Laura Coates talks to medwireNews about the latest ACR/NPF guidelines for managing psoriatic arthritis, discussing the evidence supporting the recommendations and how they compare with others.

Themed collections

29-01-2018 | Biosimilars | Themed collection | Collection

Biosimilars

This content collection provides an overview of biosimilars in rheumatology, with a focus on switching between biosimilars and their originators, as well as discussions on safety and monitoring/pharmacovigilance, and a look at the pharmacoeconomics of biosimilars.

Journal articles and book chapters

23-11-2018 | Psoriatic arthritis | Article

Assessing disease activity in psoriatic arthritis: A literature review

Tucker LJ et al. Rheumatol Ther 2018. doi: 10.1007/s40744-018-0132-4

31-10-2018 | Psoriatic arthritis | ACR/ARHP 2018 | Article

From the Editorial Board: Highlights from the 2018 ACR/ARHP Annual Meeting

Editorial board members Oliver FitzGerald and Fernando Pérez-Ruiz provide their highlights from the spondyloarthropathy and crystal arthropathy sessions at the 2018 ACR/ARHP Annual Meeting in Chicago, Illinois, USA.

Guidelines

A convenient single access point, providing rheumatology professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Images and illustrations

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

Practice tips

Practical information, guidance, and helpful resources for rheumatology healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within rheumatology management, as recommended by our Editorial Board.

Image Credits